PLoS ONE 2011, 6. e18092.[34] Liu, M.; Yuan, M.G.; Li, Z.; Cheng, Y.K.; Luo, H.-B.*; Hu, X.P.* Structural investigation into the inhibitory mechanisms of indomethacin and its analogues towards human glyoxalase I. Bioorg. Med. Chem. Lett. 2011, 21: 4243-4247.[35] Chen, Y.Y.; Chen, G.W.; Luo, H.-B.* Molecular insight into the inhibitory mechanism of galangin towards human cytochrome P450 1A2. A modeling study. Lett. Drug Des. Discov. 2011, 8: 216-222. [36] Luo, H.-B.; Zheng, H.-P.; et al. Crystal structure and molecular modeling study of N-carbamoylsarcosine amidase Ta0454 from Thermoplasma acidophilum. J. Struct. Biol.2010, 169: 304-311.[37] He, L; He, F.; Bi, H.C.; Li, J.K.; Zeng, S.;Luo, H.-B.*; Huang, M. Isoform-selective inhibition of chrysin towards human cytochrome P450 1A2. Kinetics analysis, molecular docking, and molecular dynamics simulations. Bioorg. Med. Chem. Lett.2010. 20: 6008-6012.[38] Liu, M.; He, L.; Hu, X.P.; Liu, P.Q.; Luo, H.-B.* 3D-QSAR, homology modeling, and molecular docking studies on spiropiperidines analogues as agonists of nociceptin/orphanin FQ receptor. Bioorg. Med. Chem. Lett. 2010, 20: 7004-7010.[39] Liu, M.; Yuan, M.G.; Luo, M.X.; Bu, X.Z.; Luo, H.-B.*; Hu, X.P.* Binding of curcumin with glyoxalase I: Molecular docking, molecular dynamics simulations, and kinetics analysis. Biophys. Chem. 2010, 147: 28-34.